From Novo Holding's purchase of Catalent to BMS's Karuna acquisition, here are 10 of the most significant M&A moments of 2024.

A higher risk of HF hospitalization was seen with dapagliflozin over empagliflozin, but one researcher urges caution.

As a young physiology student Tipu Aziz was inspired by watching grainy videos from the 1970s showing patients undergoing ...

Single-use technologies in biopharmaceuticals are disposable tools that improve efficiency, reduce contamination, and cut costs. They are becoming popular for producing medicines like vaccines and ...

Researchers have profiled the molecular structure and features of a key part of the deadly Nipah virus. Experiments in cells ...

However, in people with mild cognitive impairment, the presence of depressive symptoms was tied to a lower likelihood of amyloid pathology (OR 0.73, 95% CI 0.61-0.89, P =0.001), Oomens and colleagues ...

Cell Culture Media Market Is Forecasted To Reach US$ 6.94 Billion By 2034, Recording A CAGR Of 7.1% Fact.MR Report Demand for Effective and Dependable Cell Culture media Increasing in ...

Ogo Egbuna works at Vertex leading the company’s precision medicine kidney programs in APOL1-mediated and Polycystic kidney ...

In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against Prem Watsa’s other long-term stock picks. Prem Watsa is a Canadian billionaire, entrepreneur ...